Discover how we are developing STAR-0215 as a preventative therapy for HAE with dosing once every 3 and 6 months: Our Science/STAR-0215
Connect with the US HAE Association (HAEA) here: www.haea.org
Connect with the International HAE Association (HAEi) here: www.haei.org
Contact Sarah Friedhoff, our Director of Patient Advocacy here: advocacy@astriatx.com
Sign up to receive our newsletters here: Newsletters
SUBSCRIBE TO OUR NEWSLETTERS
The Astria Connection: HAE
The Astria Connection: AD
You are about to leave this website.
This link is provided as a convenience and for informational purposes only. It does not constitute an endorsement or an approval by Astria Therapeutics of any of the products, services or opinions of the corporation or organization or individual. Astria Therapeutics bears no responsibility for the accuracy, legality or content of this external site or for that of subsequent links. Please contact the external site for answers to questions regarding its content.
✕
